Related references
Note: Only part of the references are listed.Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
Tian Hua et al.
CELL (2020)
Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex
Changrui Xing et al.
CELL (2020)
Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor
Shakiru O. Alapafuja et al.
MOLECULES (2019)
Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li et al.
CELL (2019)
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal
Ai-Ling Li et al.
MOLECULAR PHARMACOLOGY (2019)
Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure-Affinity Relationship (SAfiR) and Structure-Activity Relationship (SAR) Studies
Francesco Spinelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
C1′-Azacycloalkyl Hexahydrocannabinols
Thanh C. Ho et al.
JOURNAL OF ORGANIC CHEMISTRY (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
The cannabinoid system and pain
Stephen G. Woodhams et al.
NEUROPHARMACOLOGY (2017)
One-pot palladium-catalyzed synthesis of sulfonyl fluorides from aryl bromides
Alyn T. Davies et al.
CHEMICAL SCIENCE (2017)
Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua et al.
CELL (2016)
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues
Shashank Kulkarni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE (2016)
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal
Liting Deng et al.
BIOLOGICAL PSYCHIATRY (2015)
3′-Functionalized Adamantyl Cannabinoid Receptor Probes
Go Ogawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Sulfonyl fluorides as privileged warheads in chemical biology
Arjun Narayanan et al.
CHEMICAL SCIENCE (2015)
Probing the Carboxyester Side Chain in Controlled Deactivation (-)-Δ8-Tetrahydrocannabinols
Spyros P. Nikas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Palladium-Catalyzed Synthesis of Ammonium Sulfinates from Aryl Halides and a Sulfur Dioxide Surrogate: A Gas- and Reductant-Free Process
Edward J. Emmett et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Using Deuterium in Drug Discovery: Leaving the Label in the Drug
Thomas G. Gant
JOURNAL OF MEDICINAL CHEMISTRY (2014)
2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective
Alexandros Makriyannis
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Photoactivatable Lipid Probes for Studying Biomembranes by Photoaffinity Labeling
Yi Xia et al.
CHEMICAL REVIEWS (2013)
Novel Adamantyl Cannabinoids as CB1 Receptor Probes
Ganesh A. Thakur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Sangdon Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Cannabinoid receptors: nomenclature and pharmacological principles
Linda Console-Bram et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
The endocannabinoid system and cancer: therapeutic implication
Josee Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
Elizabeth J. Rahn et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
New Method for the Synthesis of Benzyl Alkyl Ethers Mediated by FeSO4
Girdhar Joshi et al.
SYNTHETIC COMMUNICATIONS (2011)
1-Bromo-3-(1′,1′-dimethylalkyl)-1-deoxy-Δ8-tetrahydrocannabinols: New selective ligands for the cannabinoid CB2 receptor
John W. Huffman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis and structure-activity relationship of substitutions at the C-1 position of Δ9-tetrahydrocannabinol
David Burdick et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Novel 1′,1′-Chain Substituted Hexahydrocannabinols: 9/β-1-Hydroxy-3-(1-hexyl-cyclobut-l-yl)hexahydrocannabinol (AM2389) a Highly Potent Cannabinoid Receptor 1 (CB1) Agonist
Spyros P. Nikas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A Simple Analogue of Tumor-Promoting Aplysiatoxin Is an Antineoplastic Agent Rather Than a Tumor Promoter: Development of a Synthetically Accessible Protein Kinase C Activator with Bryostatin-like Activity
Yu Nakagawa et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Cannabinoid receptors: Where they are and what they do
K. Mackie
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Cannabilactones: A novel class of CB2 selective agonists with peripheral analgesic activity
Atmaram D. Khanolkar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
C1′-cycloalkyl side chain pharmacophore in tetrahydrocannabinols
Demetris P. Papahatjis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoids
Peter J. Crocker et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Adamantyl cannabinoids:: A novel class of cannabinergic ligands
D Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'
DP Papahatjis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Bifunctional pincer-type organometallics as substrates for organic transformations and as novel building blocks for polymetallic materials
G Rodríguez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Share Paper
